| Area of evaluation in zebrafish | Test compounds | Proportion of drugs with expected effects (%) | Reference |
|
Inhibition of hERG or QTc prolongation | Study 1: Amiodarone, bepridil, cisapride, haloperidol, pimozide, procainamide, D,L-sotalol, terfenadine, thioridazine | All compounds, except for procainamide | [3] | Study 2: Negative controls: amoxicillin, aspirin Positive controls: chlorpromazine, cisapride, cromakalim, isoprenaline, moxifloxacin, nicotine, verapamil | 7 out of 9 compounds, including negative controls | [1] |
|
Visual safety or optomotor response | Study 1: 27 compounds, including 19 with positive and 8 with negative effects on inhibition of optomotor response | About 70% in overall showed the predicted drug effects. | [4] | Study 2: Negative control: aspirin Positive controls: chloroquine, chlorpromazine, diazepam, nicotine, ouabain, phenytoin, atropine, lithium | 7 out of 9 compounds including negative control | [1] |
| Seizure liability | 25 drugs including 17 positive and 8 negative controls | 72% in overall | [5] |
| Gut contraction | Negative controls: aspirin and moxifloxacin Positive controls: amoxicillin, chlorpromazine, cisapride, cromakalim, isoprenaline, nicotine, nitrendipine, and verapamil | 5 out of 10 compounds including negative controls | [1] |
|
|